Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K A Schoedel

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical Pharmacology and Therapeutics|January 24, 2008
Assessing abuse liability during drug development: changing standards and expectationsK A Schoedel, E M Sellers
Biochemical Pharmacology|October 13, 2001
Induction of CYP2B1/2 and nicotine metabolism by ethanol in rat liver but not rat brainK A Schoedel, E M Sellers, R F Tyndale
Drug and Alcohol Dependence|February 19, 2013
Update on tamper-resistant drug formulationsM K Romach, K A Schoedel, E M Sellers
Clinical Pharmacology and Therapeutics|June 4, 2010
Subjective and objective effects of the novel triple reuptake inhibitor tesofensine in recreational stimulant usersK A Schoedel, D Meier, B Chakraborty, et al.
Clinical Pharmacology and Therapeutics|March 18, 2011
Evaluation of the abuse potential of lorcaserin, a serotonin 2C (5-HT2C) receptor agonist, in recreational polydrug usersM J Shram, K A Schoedel, C Bartlett, et al.
Drug and Alcohol Dependence|January 23, 2016
Assessment of human abuse potential of dasotraline compared to methylphenidate and placebo in recreational stimulant usersK S Koblan, S C Hopkins, K Sarma, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical Pharmacology and Therapeutics|January 24, 2008
Assessing abuse liability during drug development: changing standards and expectationsK A Schoedel, E M Sellers
Biochemical Pharmacology|October 13, 2001
Induction of CYP2B1/2 and nicotine metabolism by ethanol in rat liver but not rat brainK A Schoedel, E M Sellers, R F Tyndale
Drug and Alcohol Dependence|February 19, 2013
Update on tamper-resistant drug formulationsM K Romach, K A Schoedel, E M Sellers
Clinical Pharmacology and Therapeutics|June 4, 2010
Subjective and objective effects of the novel triple reuptake inhibitor tesofensine in recreational stimulant usersK A Schoedel, D Meier, B Chakraborty, et al.
Clinical Pharmacology and Therapeutics|March 18, 2011
Evaluation of the abuse potential of lorcaserin, a serotonin 2C (5-HT2C) receptor agonist, in recreational polydrug usersM J Shram, K A Schoedel, C Bartlett, et al.
Drug and Alcohol Dependence|January 23, 2016
Assessment of human abuse potential of dasotraline compared to methylphenidate and placebo in recreational stimulant usersK S Koblan, S C Hopkins, K Sarma, et al.
Pageof 1